Sector portfolio · Corporate investor · United States

Pfizer's Biotech portfolio

Pfizer has backed 45 Biotech startups in rounds we track, $5.4B between them, shown by the stage each has reached. The best-funded is Kymera Therapeutics.

45startups backed
6stages
$5.4Braised between them
Series Abiggest stage

Pfizer's profile

Series A

14

Stage not reported

10

Series B

9

Series C and later

7

Growth

3

Pre-seed and seed

2

Segment by segment

Series A

14 startups · $1.0B raised

  1. Morphic TherapeuticMorphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases.United States$328M
  2. Rhythm PharmaceuticalsRhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeuticsUnited States$311M
  3. Vivet TherapeuticsVivet Therapeutics is a biotechnology company developing gene therapy treatments for orphan diseases.France$96M
  4. TTTripley TherapeuticsUnited States$59M
  5. PPalleonUnited States$48M
  6. AArkudaUnited States$44M
  7. VVtesseUnited States$42M
  8. SStrataUnited States$32M

Stage not reported

10 startups · $582M raised

  1. CelladonCelladon is a biotechnology company developing molecular therapies for the treatment of heart failure.United States$172M
  2. MISSION TherapeuticsMission Therapeutics is a clinical-stage biopharmaceutical company based in Cambridge, UK, focused on drug discovery and developmeUnited Kingdom$113M
  3. GliknikGliknik develops therapies for patients with cancer and immune disorders.United States$78M
  4. CCydanUnited States$60M
  5. NeuMoDx MolecularNeuMoDx Molecular, Inc.United States$41M
  6. Coley Pharmaceutical GroupColey Pharmaceutical Group develops therapeutics and drug candidates to fight cancers, asthma, allergy and autoimmune disorders.United States$40M
  7. Autifony TherapeuticsAutifony Therapeutics is a clinical-stage biotechnology company founded in 2011 as a spinout from GSK.United Kingdom$32M
  8. NodalityNodality develops biologically-informed clinical treatments for patients with cancer and autoimmune diseases.United States$27M

Series B

9 startups · $1.2B raised

  1. SpringWorks TherapeuticsSpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.United States$400M
  2. CTCapstan TherapeuticsCapstan Therapeutics is advancing cell engineering to develop therapeutics for a broad range of diseases.United States$175M
  3. Arrakis TherapeuticsArrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.United States$113M
  4. ImCheck TherapeuticsImCheck Therapeutics is a developing novel therapeutics that target members of the butyrophilin (BTN) super-family of checkpoint molecules.France$97M
  5. TherachonTherachon is a global biotechnology company focused on developing medicines for rare, genetic diseasesFrance$95M
  6. 4M4D MolecularUnited States$90M
  7. CortexymeCortexyme is developing treatments for Alzheimer's and other degenerative disorders.United States$77M
  8. Nimbus TherapeuticsNimbus Therapeutics is a clinical-stage biotechnology company based in Boston, Massachusetts, founded in 2009.United States$72M

Series C and later

7 startups · $1.7B raised

  1. Kymera TherapeuticsKymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.United States$799M
  2. STORM TherapeuticsTargeting pathways that modify RNA to deliver novel cancer therapeuticsUnited Kingdom$317M
  3. Circle PharmaCircle Pharma is a provider of a macrocycle development platform intended to provide macrocyclic peptides.United States$187M
  4. Mersana TherapeuticsMersana Therapeutics develops a biodegradable polymer platform Fleximer® which creates new and better medicines.United States$148M
  5. NeuroneticsNeuronetics is a medical device company that develops non-invasive therapies for psychiatric and neurological disorders.United States$110M
  6. RRefleXionReflexion offers holistic fitness through Pilates and Gyrotonic exercise.United States$100M
  7. HHandyLabHandyLab is a business that provides the world with research into medical technology.United States$24M

Growth

3 startups · $836M raised

  1. CellCentricCellCentric is a clinical-stage biopharmaceutical company based in Cambridge, UK.United Kingdom$525M
  2. Epic SciencesEpic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.United States$165M
  3. FPFive Prime TherapeuticsFivePrime is a clinical-stage biotechnology company that develops treatments for cancers.United States$146M

Pre-seed and seed

2 startups · $50M raised

  1. RRhythmUnited States$42M
  2. MSMolecular StethoscopeUnited States$8.2M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Pfizer as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Co-investorsWho invests with Pfizer43 co-investorsSector portfolioCoinbase Ventures' Web3 & Crypto portfolio168 startups · $5.7BSector portfolioSalesforce Ventures' AI portfolio115 startups · $181BSector portfolioGoogle Ventures' AI portfolio81 startups · $16BSector portfolioGoogle Ventures' Biotech portfolio74 startups · $12BSector portfolioSamsung Next's AI portfolio72 startups · $9.8B

Raising from investors like Pfizer?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps